Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cohen Ron, Chief Executive Officer. Director active across 3 companies, notably Acorda Therapeutics INC. Aggregated, 10 filings have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €9k. History available since 3 September 2021. The latest transaction was disclosed on 16 March 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Cohen Ron is Président et Directeur Général. He has 10 filings in total, and across the recent sample of 10 filings, the transactions include buys of EUR 5758 and sells of EUR 3533 between 2016-01-19 and 2023-03-20, with the most common transaction nature indicated as Levée d'options.